Welcome Longenesis to AmCham

Sep 21, 2022

Longenesis, a medical technology startup company, has joined the Chamber as a Corporate member. The startup is working towards providing a technological bridge between Healthcare institutions and the BioTech industry with an aim to help identify and unlock the hidden value of biomedical data to accelerate the novel drug and treatment discovery and provide better help to those in need.

Their team has experience working with the clinical organizations and unlocking the potential for accelerating the R&D process around the globe, including National level projects in the Middle East, U.S., Baltic and APAC regions.

In the Chamber it will be represented by Emil Syundyukov, Chief Technology Officer.

A warm welcome to AmCham community!

< Back to News




We are very pleased to be part of AmCham and are looking forward to driving innovation forward in Latvia.

Mikko Fernström, General Manager, Biogen Latvia

We re-affirm our commitment to the values that AmCham stands for and that we share.

Kārlis Danēvičs, Board member, Head of Credits and Risk at SEB Banka